A subarachnoid hemorrhage (SAH) is bleeding in the space between the brain and the surrounding membrane (subarachnoid space), causing a sudden and severe headache. Bleeding that results from the rupture of an abnormal bulge in a blood vessel (aneurysm) in the brain is known as Aneurysmal Subarachnoid Hemorrhage (aSAH).
Most spontaneous SAHs result from the rupture of intracranial aneurysms; therefore, risk factors for aneurysm formation overlap with risk factors for SAH such as smoking, hypertension, alcohol abuse, genetic risk, and others.
Additionally, the most common presenting feature of an aneurysm is SAH—as most often described by the patient, SAH most commonly presents as a severe headache. Headache induced by SAH is most often associated with nausea, vomiting, neck rigidity, and photophobia.
DelveInsight's "Aneurysmal Subarachnoid Hemorrhage Market Insights, Epidemiology, and Market Forecast 2030" report delivers an in-depth understanding of the Aneurysmal Subarachnoid Hemorrhage, historical and forecasted epidemiology as well as the Aneurysmal Subarachnoid Hemorrhage market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Aneurysmal Subarachnoid Hemorrhage Market Key Facts
-
The incident cases of aSAH is more common in females as compared to males.
-
The majority of SAH patients develop angiographic vasoconstriction (up to 70%), and only around 20–30% develop DCI [As per the study conducted by Francoeur et al.].
-
The study conducted by Tamimi et al.”estimated the incidence of aneurysmal subarachnoid hemorrhage (aSAH) to be 6–8 per 100,000 annually, with a peak incidence in the fifth decade”.
Key Benefits of Aneurysmal Subarachnoid Hemorrhage Market Report
-
Aneurysmal Subarachnoid Hemorrhage market report provides an in-depth analysis of Aneurysmal Subarachnoid Hemorrhage Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
-
The Aneurysmal Subarachnoid Hemorrhage market report will help in developing business strategies by understanding the Aneurysmal Subarachnoid Hemorrhage Market trends & developments, key players and future market competition that will shape and drive the Aneurysmal Subarachnoid Hemorrhage market in the upcoming years.
-
The Aneurysmal Subarachnoid Hemorrhage market report covers Aneurysmal Subarachnoid Hemorrhage current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
-
The report provides a detailed assessment of the Aneurysmal Subarachnoid Hemorrhage market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Aneurysmal Subarachnoid Hemorrhage Market Forecast
The Aneurysmal Subarachnoid Hemorrhage market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Aneurysmal Subarachnoid Hemorrhage market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Aneurysmal Subarachnoid Hemorrhage market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Aneurysmal Subarachnoid Hemorrhage Epidemiology
The Aneurysmal Subarachnoid Hemorrhage epidemiology section covers insights about historical and current Aneurysmal Subarachnoid Hemorrhage patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Aneurysmal Subarachnoid Hemorrhage Pipeline Analysis and Key Companies
The Aneurysmal Subarachnoid Hemorrhage Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Aneurysmal Subarachnoid Hemorrhage market or expected to get launched in the market during the study period. The analysis covers Aneurysmal Subarachnoid Hemorrhage market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
For more detailed information on Aneurysmal Subarachnoid Hemorrhage Market Forecast visit:
https://www.delveinsight.com/report-store/aneurysmal-subarachnoid-hemorrhage-sah-market